Wolverine Asset Management LLC Bluebird Bio, Inc. Transaction History

Wolverine Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$18.04 - $22.09 $2,922 - $3,578	-162 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$16.59 - $33.89 $56,007 - $114,412	-3,376 Reduced 95.42%	162 $4,000
Q4 2020 Feb 12, 2021	BUY	$27.5 - $37.92 $67,375 - $92,904	2,450 Added 225.18%	3,538 $153,000
Q3 2020 Nov 13, 2020	SELL	$34.44 - $43.75 $551 - $700	-16 Reduced 1.45%	1,088 $58,000
Q2 2020 Aug 13, 2020	BUY	$27.12 - $45.97 $29,940 - $50,750	1,104 New	1,104 $67,000
Q1 2020 May 13, 2020	SELL	$26.16 - $63.5 $2,302 - $5,588	-88 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$64.44 - $104.11 $5,670 - $9,161	88 New	88 $13,000

152

63.7M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $24.7M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.